Arsanis

In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
Endpoints
Tue, 11/27/18 - 11:29 pm
biotech
reverse merger
M&A
Arsanis
X4 Pharma
Arsanis Discontinues Ph II Trial of ASN100
CP Wire
Thu, 06/28/18 - 09:48 am
Arsanis
ASN100
pneumonia
monoclonal antibodies